Mashukur Rahman/LinkedIn
Feb 8, 2026, 14:09
Mashukur Rahman: New ESC Dyslipidemia Updates Expand the Role of Statins
Mashukur Rahman, Resident Doctor at Bangladesh Medical University, Medical Officer at Directorate General of Health Services, shared a post on LinkedIn.
“Many doctors still think statins are only for high LDL cholesterol.
But the new ESC dyslipidemia updates suggest a bigger role.
Why this matters now:
- Statins may help protect the heart in some cancer patients.
Some chemotherapy drugs like anthracyclines can cause heart failure years later. Preventive statin use is getting stronger support. - We are moving from treating numbers to treating overall risk.
Risk builds silently, even when LDL is not very high.
In real life, we often wait for LDL to cross a ‘clear cutoff.’
But by then, damage may already be starting.
If statins are becoming broader heart-protection drugs — when should we start them in borderline-risk patients?”
Stay updated with Hemostasis Today.
-
Feb 8, 2026, 13:58Alan Nurden: A “Gold Medal” Study on Silk Fibroin 3D Models for Bone Marrow Fibrosis
-
Feb 8, 2026, 13:45Shinya Goto։ New Lancet Meta-Analysis on Statin-Related Adverse Effects
-
Feb 8, 2026, 13:29Andrea Marshall: Highlighting the Impact of PBM Conference 2026 on Patient-Centred Blood Care
-
Feb 8, 2026, 13:12OncoDaily’s Managing Editor Elen Baloyan Releases Her First Mini-EP
-
Feb 8, 2026, 12:57Shiny K. Kajal: A Hidden Cause of Persistent Mild Anemia
-
Feb 8, 2026, 12:54Gokul Patil Receives AHA Funding to Investigate Thrombo-Inflammatory Mechanisms Underlying Long COVID
-
Feb 7, 2026, 17:00Heghine Khachatryan: Despite Progress, Many People with Hemophilia Remain Undiagnosed Worldwide
-
Feb 7, 2026, 16:53Priyansh Shah and Romit Bhattacharya Address Patients’ Concerns on GLP-1
-
Feb 7, 2026, 16:43Wolfgang Miesbach: Comparing Clinician-Assessed and Patient-Reported Bleeding Scores and Quality of Life